{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T12:21:30Z","timestamp":1789042890412,"version":"build-2803163510"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":78,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-13847-w","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T09:16:25Z","timestamp":1782292585000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Staphylococcus aureus bacteremia: clinical outcomes and predictors of 28-day mortality in a tertiary-care cohort"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-3452-1816","authenticated-orcid":false,"given":"Merve Nur","family":"Gucluer Kocaoglu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasip","family":"Kahraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayg\u0131n","family":"Nayman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nurettin","family":"Erben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif Doyuk","family":"Kartal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,24]]},"reference":[{"issue":"1","key":"13847_CR1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.amjmed.2022.09.017","volume":"136","author":"JC Lam","year":"2023","unstructured":"Lam JC, Stokes W. The golden grapes of wrath \u2013 Staphylococcus aureus bacteremia: a clinical review. Am J Med. 2023;136(1):19\u201326. https:\/\/doi.org\/10.1016\/j.amjmed.2022.09.017.","journal-title":"Am J Med"},{"issue":"9","key":"13847_CR2","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1001\/jama.2025.4288","volume":"334","author":"SYC Tong","year":"2025","unstructured":"Tong SYC, Fowler VG, Skalla L, Holland TL. Management of Staphylococcus aureus bacteremia: a review. JAMA. 2025;334(9):798\u2013808. https:\/\/doi.org\/10.1001\/jama.2025.4288.","journal-title":"JAMA"},{"issue":"2","key":"13847_CR3","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.jiac.2019.10.003","volume":"26","author":"T Horino","year":"2020","unstructured":"Horino T, Hori S. Metastatic infection during Staphylococcus aureus bacteremia. J Infect Chemother. 2020;26(2):162\u201369. https:\/\/doi.org\/10.1016\/j.jiac.2019.10.003.","journal-title":"J Infect Chemother"},{"issue":"3","key":"13847_CR4","doi-asserted-by":"publisher","first-page":"454","DOI":"10.3390\/antibiotics12030454","volume":"12","author":"S Kitaya","year":"2023","unstructured":"Kitaya S, Kanamori H, Katori Y, Tokuda K. Clinical characteristics and outcomes of persistent staphylococcal bacteremia in a tertiary care hospital. Antibiotics. 2023;12(3):454. https:\/\/doi.org\/10.3390\/antibiotics12030454.","journal-title":"Antibiotics"},{"issue":"1","key":"13847_CR5","doi-asserted-by":"publisher","first-page":"30709","DOI":"10.1038\/s41598-025-16137-8","volume":"15","author":"D Borcak","year":"2025","unstructured":"Borcak D, Ozdemir YE, Yesilbag Z, Akkaya S, Ensaroglu E, Sezen AIUnlu EC, et al. Clinical and laboratory predictors of mortality in Staphylococcus aureus bacteremia. Sci Rep. 2025;15(1):30709. https:\/\/doi.org\/10.1038\/s41598-025-16137-8.","journal-title":"Sci Rep"},{"issue":"1","key":"13847_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/23744235.2022.2123561","volume":"55","author":"JR Hindy","year":"2023","unstructured":"Hindy JR, Quintero-Martinez JA, Lahr BD, DeSimone DC, Baddour LM. Staphylococcus aureus bacteraemia and mortality: a population-based study in olmsted county, Minnesota, from 2006 to 2020. Infect Dis. 2023;55(1):1\u20138. https:\/\/doi.org\/10.1080\/23744235.2022.2123561.","journal-title":"Infect Dis"},{"key":"13847_CR7","doi-asserted-by":"publisher","unstructured":"Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJKaplan SL, et al. Clinical practice guidelines by the Infectious Diseases society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in Adults and children. Clin Infect Dis. 2011;52(3):e18\u201355. https:\/\/doi.org\/10.1093\/cid\/ciq146.","DOI":"10.1093\/cid\/ciq146"},{"key":"13847_CR8","doi-asserted-by":"publisher","first-page":"1718336","DOI":"10.3389\/fpubh.2025.1718336","volume":"13","author":"S Rutare","year":"2026","unstructured":"Rutare S, Masaisa F, Nkubana T, Dusabe A, Munyemana JB. Understanding the burden and impact of methicillin-resistant Staphylococcus aureus: exploring therapeutic options and hospital prevention strategies to improve patient outcome at the University teaching hospital of Kigali, Rwanda. Front Public Health. 2026;13:1718336. https:\/\/doi.org\/10.3389\/fpubh.2025.1718336.","journal-title":"Front Public Health"},{"key":"13847_CR9","unstructured":"World Health Organization. Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%). WHO data Explorer. 2025. https:\/\/data.who.int\/indicators\/i\/918081E\/5DD9606. 7 Apr 2026."},{"issue":"7","key":"13847_CR10","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.3390\/microorganisms13071519","volume":"13","author":"GA Urriago-Osorio","year":"2025","unstructured":"Urriago-Osorio GA, Lozada-Ramos H, Daza-Arana JE, Ruiz-Jim\u00e9nez PA, Rivas-Tafurt GP, Bonilla-Bonilla DM. Comparison of clinical characteristics and outcomes between MRSA and MSSA infections among patients in intensive care units. Microorganisms. 2025;13(7):1519. https:\/\/doi.org\/10.3390\/microorganisms13071519.","journal-title":"Microorganisms"},{"issue":"2","key":"13847_CR11","doi-asserted-by":"publisher","first-page":"131","DOI":"10.53854\/liim-3202-2","volume":"32","author":"SS Adeiza","year":"2024","unstructured":"Adeiza SS, Aminul I. Meta-meta-analysis of the mortality risk associated with MRSA compared to MSSA bacteraemia. Infez Med. 2024;32(2):131\u201337. https:\/\/doi.org\/10.53854\/liim-3202-2.","journal-title":"Infez Med"},{"key":"13847_CR12","doi-asserted-by":"publisher","unstructured":"Abdollahi A, Nojomi M, Karimi Y, Ranjbar M. Mortality patterns in patients with Staphylococcus aureus bacteremia during the COVID-19 pandemic: predictors and insights. Heliyon. 2024;10(2):e24511. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e24511.","DOI":"10.1016\/j.heliyon.2024.e24511"},{"issue":"1","key":"13847_CR13","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1186\/s12879-025-12040-9","volume":"25","author":"TH No","year":"2025","unstructured":"No TH, Mun SJ. Time to initial glycopeptide therapy and 30-day mortality in methicillin-resistant Staphylococcus aureus bacteremia: a retrospective cohort study. BMC Infect Dis. 2025;25(1):1614. https:\/\/doi.org\/10.1186\/s12879-025-12040-9.","journal-title":"BMC Infect Dis"},{"key":"13847_CR14","doi-asserted-by":"publisher","unstructured":"Schweizer ML, Furuno JP, Harris AD, Johnson JK, Shardell MD, McGregor JCThom KA, et al. Empiric antibiotic therapy for Staphylococcus aureus bacteremia may not reduce in-hospital mortality: a retrospective cohort study. PLoS One. 2010;5(7):e11432. https:\/\/doi.org\/10.1371\/journal.pone.0011432.","DOI":"10.1371\/journal.pone.0011432"},{"issue":"10","key":"13847_CR15","doi-asserted-by":"publisher","first-page":"791","DOI":"10.7326\/0003-4819-137-10-200211190-00007","volume":"137","author":"ND Friedman","year":"2002","unstructured":"Friedman ND, Kaye KS, Stout JE, McGarry SA, Trivette SL, Briggs JPLamm W, et al. Health care\u2013associated bloodstream infections in Adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med. 2002;137(10):791\u201397. https:\/\/doi.org\/10.7326\/0003-4819-137-10-200211190-00007.","journal-title":"Ann Intern Med"},{"key":"13847_CR16","unstructured":"The European Committee on antimicrobial susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 16.0. 2026. https:\/\/www.eucast.org\/bacteria\/clinical-breakpoints-and-interpretation\/clinical-breakpoint-tables\/. 9 Apr 2026."},{"issue":"2","key":"13847_CR17","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1128\/CMR.05022-11","volume":"25","author":"SJ Van Hal","year":"2012","unstructured":"Van Hal SJ, Jensen SO, Vaska VL, Espedido BA, Paterson DL, Gosbell IB. Predictors of mortality in Staphylococcus aureus bacteremia. Clin Microbiol Rev. 2012;25(2):362\u201386. https:\/\/doi.org\/10.1128\/CMR.05022-11.","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"13847_CR18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13756-025-01671-x","volume":"15","author":"R Fattore","year":"2025","unstructured":"Fattore R, Conflitti C, Scaglione G, De Capitani G, Borgonovo F, Zizzo DSchiavini M, et al. Risk factors associated with mortality in patients with catheter-related and catheter-associated bloodstream infections: a retrospective observational study focused on CVADs and midlines. Antimicrob Resist Infect Control. 2025;15(1):9. https:\/\/doi.org\/10.1186\/s13756-025-01671-x.","journal-title":"Antimicrob Resist Infect Control"},{"key":"13847_CR19","doi-asserted-by":"publisher","unstructured":"Bae S, Kook MS, Chang E, Jung J, Kim MJ, Chong YPKim S-H, et al. Risk factors for infection-attributable mortality in patients with Staphylococcus aureus bacteremia: a competing risk analysis. Open Forum Infect Dis. 2024;12(1):ofae734. https:\/\/doi.org\/10.1093\/ofid\/ofae734.","DOI":"10.1093\/ofid\/ofae734"},{"key":"13847_CR20","doi-asserted-by":"publisher","unstructured":"Van Der Vaart TW, Prins JM, Soetekouw R, Van Twillert G, Veenstra J, Herpers BLRozemeijer W, et al. All-cause and infection-related mortality in Staphylococcus aureus bacteremia, a multicenter prospective cohort study. Open Forum Infect Dis. 2022;9(12):ofac653. https:\/\/doi.org\/10.1093\/ofid\/ofac653.","DOI":"10.1093\/ofid\/ofac653"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-13847-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13847-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13847-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T12:02:30Z","timestamp":1789041750000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-13847-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,24]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13847"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-13847-w","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,24]]},"assertion":[{"value":"12 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the principles of the Declaration of Helsinki and approved by the Eski\u015fehir Osmangazi University Non-Interventional Clinical Research Ethics Committee (Decision No: 35, Date: June 20, 2023). The requirement for informed consent was waived by the Eskisehir Osmangazi University Faculty of Medicine Non-Interventional Clinical Research Ethics Committee due to the retrospective nature of the study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1624"}}